Hologic Inc
Symbol: HOLX (NASDAQ)
67.57
▲ (0.79%) 0.530
Company Description:
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Key Stats
- Today's Open: $66.86
- Today's High: $68.275
- Today's Low: $66.57
- Today's Volume: 1.77M
- Yesterday Close: $67.04
- Yesterday High: $68.5
- Yesterday Low: $66.64
- Yesterday Volume: 2.24M
- Last Min Volume: 13
- Last Min High: $67.57
- Last Min Low: $67.57
- Last Min VWAP: $67.57
Company Profile
- Name: Hologic Inc
- Website: https://www.hologic.com
- Listed Date: 1990-03-01
- Location: MARLBOROUGH, MA
- Market Status: Active
- CIK Number: 0000859737
- SIC Code: 3844
- SIC description: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
- Market Cap: $14.91B
- Round Lot: 100
- Outstanding Shares: 222.42M
- Asset Type: CS
RECENT FILINGS FOR HOLX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-23 | 4 | View |
| 2025-09-22 | 144 | View |
| 2025-09-19 | 8-K | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-30 | 8-K | View |
| 2025-07-18 | 8-K | View |
| 2025-07-08 | SCHEDULE 13G/A | View |
| 2025-06-03 | 4 | View |
| 2025-05-23 | SD | View |
| 2025-05-09 | 4 | View |
| 2025-05-02 | 3 | View |
| 2025-05-02 | 10-Q | View |
| 2025-05-01 | 8-K | View |
| 2025-04-17 | SCHEDULE 13G/A | View |
| 2025-04-09 | 4 | View |
| 2025-04-09 | 3 | View |
| 2025-04-04 | 8-K | View |
| 2025-03-03 | 8-K | View |
| 2025-02-28 | 4 | View |
| 2025-02-28 | 4 | View |
Latest News on HOLX